|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quivy A, Daste A, Harbaoui A, Duc S,
Bernhard JC, Gross-Goupil M and Ravaud A: Optimal management of
renal cell carcinoma in the elderly: a review. Clin Interv Aging.
8:433–442. 2013.PubMed/NCBI
|
|
3
|
Rathmell WK and Godley PA: Recent updates
in renal cell carcinoma. Curr Opin Oncol. 22:250–256. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vasudev NS, Selby PJ and Banks RE: Renal
cancer biomarkers: the promise of personalized care. BMC Med.
10:1122012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Edgar BA: From cell structure to
transcription: Hippo forges a new path. Cell. 124:267–273. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao B, Li L, Lei Q and Guan KL: The
Hippo-YAP pathway in organ size control and tumorigenesis: an
updated version. Genes Dev. 24:862–874. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao B, Wei X, Li W, et al: Inactivation
of YAP oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stanger BZ: Quit your YAPing: a new target
for cancer therapy. Genes Dev. 26:1263–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Ji JY, Yu M, et al: YAP-dependent
induction of amphiregulin identifies a non-cell-autonomous
component of the Hippo pathway. Nat Cell Biol. 11:1444–1450. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bao Y, Hata Y, Ikeda M and Withanage K:
Mammalian Hippo pathway: from development to cancer and beyond. J
Biochem. 149:361–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong J, Feldmann G, Huang J, et al:
Elucidation of a universal size-control mechanism in
Drosophila and mammals. Cell. 130:1120–1133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao B, Tumaneng K and Guan KL: The Hippo
pathway in organ size control, tissue regeneration and stem cell
self-renewal. Nat Cell Biol. 13:877–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harvey K and Tapon N: The
Salvador-Warts-Hippo pathway - an emerging tumour-suppressor
network. Nat Rev Cancer. 7:182–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sawada A, Kiyonari H, Ukita K, Nishioka N,
Imuta Y and Sasaki H: Redundant roles of Tead1 and
Tead2 in notochord development and the regulation of cell
proliferation and survival. Mol Cell Biol. 28:3177–3189. 2008.
|
|
16
|
Chan SW, Lim CJ, Chen L, Chong YF, Huang
C, Song H and Hong W: The Hippo pathway in biological control and
cancer development. J Cell Physiol. 226:928–939. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lamar JM, Stern P, Liu H, Schindler JW,
Jiang ZG and Hynes RO: The Hippo pathway target, YAP, promotes
metastasis through its TEAD-interaction domain. Proc Natl Acad Sci
USA. 109:E2441–E2450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zender L, Spector MS, Xue W, et al:
Identification and validation of oncogenes in liver cancer using an
integrative oncogenomic approach. Cell. 125:1253–1267. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H, Wolfe A, Septer S, et al:
Deregulation of Hippo kinase signalling in human hepatic
malignancies. Liver Int. 32:38–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Steinhardt AA, Gayyed MF, Klein AP, et al:
Expression of Yes-associated protein in common solid tumors. Hum
Pathol. 39:1582–1589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Smolen GA and Haber DA: Negative
regulation of YAP by LATS1 underscores evolutionary conservation of
the Drosophila Hippo pathway. Cancer Res. 68:2789–2794.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao B, Li L, Wang L, Wang CY, Yu J and
Guan KL: Cell detachment activates the Hippo pathway via
cytoskeleton reorganization to induce anoikis. Genes Dev. 26:54–68.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Dong Q, Zhang Q, Li Z, Wang E and
Qiu X: Overexpression of yes-associated protein contributes to
progression and poor prognosis of non-small-cell lung cancer.
Cancer Sci. 101:1279–1285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu MZ, Yao TJ, Lee NP, et al:
Yes-associated protein is an independent prognostic marker in
hepatocellular carcinoma. Cancer. 115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muramatsu T, Imoto I, Matsui T, et al: YAP
is a candidate oncogene for esophageal squamous cell carcinoma.
Carcinogenesis. 32:389–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diep CH, Zucker KM, Hostetter G, et al:
Down-regulation of Yes associated protein 1 expression reduces cell
proliferation and clonogenicity of pancreatic cancer cells. PLoS
One. 7:e327832012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tufail R, Jorda M, Zhao W, Reis I and
Nawaz Z: Loss of Yes-associated protein (YAP) expression is
associated with estrogen and progesterone receptors negativity in
invasive breast carcinomas. Breast Cancer Res Treat. 131:743–750.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakuma T, Barry MA and Ikeda Y: Lentiviral
vectors: basic to translational. Biochem J. 443:603–618. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abbas-Terki T, Blanco-Bose W, Déglon N,
Pralong W and Aebischer P: Lentiviral-mediated RNA interference.
Hum Gene Ther. 13:2197–2201. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Santamaria J, Khalfallah O, Sauty C, et
al: Silencing of choline acetyltransferase expression by
lentivirus-mediated RNA interference in cultured cells and in the
adult rodent brain. J Neurosci Res. 87:532–544. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Strano S, Monti O, Pediconi N, et al: The
transcriptional coactivator Yes-associated protein drives p73
gene-target specificity in response to DNA damage. Mol Cell.
18:447–459. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Zhao B, Wang P, et al: Structural
insights into the YAP and TEAD complex. Genes Dev. 24:235–240.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao B, Ye X, Yu J, et al: TEAD mediates
YAP-dependent gene induction and growth control. Genes Dev.
22:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao X, Pfaff SL and Gage FH: YAP regulates
neural progenitor cell number via the TEA domain transcription
factor. Genes Dev. 22:3320–3334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu-Chittenden Y, Huang B, Shim JS, et al:
Genetic and pharmacological disruption of the TEAD-YAP complex
suppresses the oncogenic activity of YAP. Genes Dev. 26:1300–1305.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ota M and Sasaki H: Mammalian Tead
proteins regulate cell proliferation and contact inhibition as
transcriptional mediators of Hippo signaling. Development.
135:4059–4069. 2008. View Article : Google Scholar : PubMed/NCBI
|
